FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Vanta Bioscience IPO and Worth Peripherals IPO.
Vanta Bioscience IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Worth Peripherals IPO is a SME Book Built Issue proposed to list at NSE SME.
Vanta Bioscience IPO | Worth Peripherals IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Book Built Issue |
Listing At | BSE SME | NSE SME |
Lead Managers | Inventure Merchant Banker Services Pvt Ltd | Pantomath Capital Advisors Pvt Ltd |
Registrar | Bigshare Services Pvt Ltd | Bigshare Services Pvt Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL |
The total issue size of Vanta Bioscience IPO is up to ₹7.56 Cr whereas the issue size of the Worth Peripherals IPO is up to ₹18.28 Cr. The final issue price of Vanta Bioscience IPO is ₹50.00 per share and of Worth Peripherals IPO is ₹43.00 per share.
Vanta Bioscience IPO | Worth Peripherals IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹40.00 per share | |
Issue Price (Upper) | ₹43.00 per share | |
Issue Price (Final) | ₹50.00 per share | ₹43.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 3000 shares | 3000 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | ||
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 15,12,000 shares | 42,51,000 shares |
Issue Size Total (Amount) | up to ₹7.56 Cr | up to ₹18.28 Cr |
Vanta Bioscience IPO opens on Sep 25, 2017, while Worth Peripherals IPO opens on Sep 15, 2017. The closing date of Vanta Bioscience IPO and Worth Peripherals IPO is Sep 27, 2017, and Sep 19, 2017, respectively.
Vanta Bioscience IPO | Worth Peripherals IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Sep 25, 2017 | Sep 15, 2017 |
Issue Close | Sep 27, 2017 | Sep 19, 2017 |
Basis Of Allotment (Tentative) | ||
Initiation of Refunds (Tentative) | ||
Credit of Share (Tentative) | ||
Listing date (Tentative) | ||
Anchor Lockin End date 1 | ||
Anchor Lockin End date 2 |
Vanta Bioscience IPO P/E ratio is , as compared to Worth Peripherals IPO P/E ratio of .
Vanta Bioscience IPO | Worth Peripherals IPO | ||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | |||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||
P/E Ratio | |||||||||||||||||||||||||||||||||
Market Cap | |||||||||||||||||||||||||||||||||
ROE | |||||||||||||||||||||||||||||||||
ROCE | |||||||||||||||||||||||||||||||||
Debt/Equity | |||||||||||||||||||||||||||||||||
EPS | |||||||||||||||||||||||||||||||||
RoNW |
In the Vanta Bioscience IPO retail investors (RII) are offered while in Worth Peripherals IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Vanta Bioscience IPO and 0 shares in Worth Peripherals IPO.
Vanta Bioscience IPO | Worth Peripherals IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 0 shares | |
NII | 21,25,500 shares | |
RII | 21,25,500 shares | |
Employee | ||
Others | ||
Total | 42,51,000 shares |
Vanta Bioscience IPO subscribed in total, whereas Worth Peripherals IPO subscribed 2.62x.
Vanta Bioscience IPO | Worth Peripherals IPO | |
---|---|---|
QIB (times) | ||
NII (times) | 1.77x | |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 3.25x | |
Employee (times) | ||
Other (times) | ||
Total (times) | 2.62x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|